AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nissui Pharmaceutical Co., Ltd.
  3. Financials
  4. Net income

Nissui Pharmaceutical Co., Ltd.【JP:E00971】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 20221,146+76.85%
Mar 31, 2021648+61.60%
Mar 31, 2020401-48.85%
Mar 31, 2019784-33.28%
Mar 31, 20181,175-38.25%
Mar 31, 20171,903-6.77%
Mar 31, 20162,041-17.40%
Mar 31, 20152,471+7.16%
Mar 31, 20142,306+3.31%
Mar 31, 20132,232+38.13%
Mar 31, 20121,616

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)